Clinical and pharmacokinetic study of TNP-470, an angiogenesis inhibitor, in combination with paclitaxel and carboplatin in patients with solid tumors

Author： Tran Hai   Blumenschein George   Lu Charles   Meyers Christina   Papadimitrakopoulou Vali   Fossella Frank   Zinner Ralph   Madden Timothy   Smythe Lori   Puduvalli Vinay   Munden Reggie   Truong Mylene   Herbst Roy  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.54, Iss.4, 2004-10, pp. : 308-314

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Phase I Study of CT-2103, A Polymer-Conjugated Paclitaxel, and Carboplatin in Patients with Advanced Solid Tumors

By Nemunaitis John   Cunningham Casey   Senzer Neil   Gray Megan   Oldham Fred   Pippen John   Mennel Robert   Eisenfeld Amy  

Cancer Investigation, Vol. 23, Iss. 8, 2005-11 ,pp. : 671-676

Informa Healthcare

Access to resources Recommend Favorite

The clinical development of paclitaxel and the paclitaxel/carboplatin combination

By Schwartz G.N.   Pendyala L.   Kindler H.   Meropol N.   Perez R.   Raghavan D.   Creaven P.  

European Journal of Cancer, Vol. 34, Iss. 10, 1998-09 ,pp. : 1543-1548

Elsevier

Access to resources Recommend Favorite

A phase I and pharmacologic study of sequences of the proteasome inhibitor, bortezomib (PS-341, Velcade™), in combination with paclitaxel and carboplatin in patients with advanced malignancies

By Ma Cynthia   Mandrekar Sumithra   Alberts Steven   Croghan Gary   Jatoi Aminah   Reid Joel   Hanson Lorelei   Bruzek Laura   Tan Angelina   Pitot Henry   Erlichman Charles   Wright John   Adjei Alex  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 2, 2007-02 ,pp. : 207-215

Springer Publishing Company

Access to resources Recommend Favorite

Phase 1 study of the investigational, oral angiogenesis inhibitor motesanib in Japanese patients with advanced solid tumors

By Fujisaka Yasuhito   Yamada Yasuhide   Yamamoto Noboru   Shimizu Toshio   Fujiwara Yutaka   Yamada Kazuhiko   Tamura Tomohide   Watanabe Hiroyuki   Sun Yu-Nien   Bass Michael   Seki Mitsuo  

Cancer Chemotherapy and Pharmacology, Vol. 66, Iss. 5, 2010-10 ,pp. : 935-943

Springer Publishing Company

Access to resources Recommend Favorite

Inhibition of tumor growth and metastasis by angiogenesis inhibitor TNP-470 on breast cancer cell lines in vitro and in vivo

By Singh Y.  

Breast Cancer Research and Treatment, Vol. 45, Iss. 1, 1997-08 ,pp. : 15-27

Springer Publishing Company

Access to resources Recommend Favorite